Clinical Trials Directory

Trials / Completed

CompletedNCT04918290

Tegaderm Vs. Transpore for Eye Protection During Anesthesia

A Randomized Controlled Trial of Tegaderm Vs. Transpore for Eye Protection During Anesthesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
165 (actual)
Sponsor
Tufts Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the rate of eyelid erythema after anesthesia with the use of TegadermTM vs. the Transpore®. Our null hypothesis is that the rate of erythema will be similar between the two groups given there is no evidence currently to suggest otherwise

Detailed description

At Tufts Medical Center, a variety of adhesive tapes are used to shut the eyes during anesthesia, including 3MTM TegadermTM and the Sharn Anesthesia Transpore®, with no preference for one or the other. While all of these products decrease the risk of corneal abrasion, none of these products have been shown to be superior to the others in terms of eyelid irritation. According to Sharn Anesthesia, "The \[Transpore®\] adhesive is light enough to reduce damage to the outer eye" (3). However, there is no scientific evidence to support this claim. All the investigators know is that the Transpore is coated with a medical grade, pressure-sensitive acrylic adhesive and that there are no phthalates, it is latex free and silicone free.

Conditions

Interventions

TypeNameDescription
DEVICETegaderm Eye TapeEye tape to protect the eye from corneal abrasions during surgery.
DEVICETranspore Eye TapeEye tape to protect the eye from corneal abrasions during surgery.

Timeline

Start date
2021-06-11
Primary completion
2024-04-17
Completion
2024-05-15
First posted
2021-06-08
Last updated
2024-10-28

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04918290. Inclusion in this directory is not an endorsement.